The slip
PARKINSON RECEIPTno. 7104
23 Oct 2026, 02:50 UTColigodendrocytes, braak
predictionVIPR2 in oligodendrocytes tracks Braak Lewy-body stage
registered6d00052cf6b1f32b
discovery+0.20 p=0.597 n=9
replication-0.11 p=0.785 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.20, p 0.597)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTfd261f987ee41fb9168efe55…
follows 8e9dd511c2ec…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7104: VIPR2 in oligodendrocytes, braak
- power
- full sample +0.01 (p 0.969, n 18), 95% CI -0.46 to +0.47. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.02 (p 0.949, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.23 (p 0.369, n 18). could be the mix.
- skeptic
- leave-one-out range -0.11 to +0.14, sign flips 8; without severely affected donors +0.01 (p 0.969, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for VIPR2 in oligodendrocytes.
case closed: nothing better to follow up.